This analytical study evaluates a novel immunoassay for cardiac troponin T, highlighting its effectiveness in distinguishing myocardial infarction from end-stage renal disease.
Key Points
The long cTnT assay showed a limit of detection of 10.8 ng/L, indicating high sensitivity.
Using heparin plasma improved long cTnT detection compared to serum samples in analysis.
Stability studies revealed that long cTnT was compromised at higher temperatures, emphasizing proper sample storage.
Long cTnT levels decreased over time after the onset of type 1 myocardial infarction.